Clinical trial
A Clinical Safety and Efficacy Evaluation of Zylet® Versus Tobradex in the Treatment of Blepharokeratoconjunctivitis
NCT01028027 is registered in ClinicalTrials.gov with Bausch & Lomb Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Safety and Efficacy Evaluation of Zylet® Versus Tobradex in the Treatment of Blepharokeratoconjunctivitis
- Lead sponsor
- Bausch & Lomb Incorporated
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- March 31, 2010
- Enrollment
- 357 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.